RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM) Article

Wen, Patrick, Odia, Yazmin, Mehta, Minesh et al. (2020). RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM) . NEURO-ONCOLOGY, 22(Supplement_2), ii195-ii195. 10.1093/neuonc/noaa215.813

cited authors

  • Wen, Patrick; Odia, Yazmin; Mehta, Minesh; Goldlust, Samuel; Tamir, Sharon; Shacham, Sharon; Wang, Hongwei; Sheehan, Heidi; Li, Kai

authors

publication date

  • November 9, 2020

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • ii195

end page

  • ii195

volume

  • 22

issue

  • Supplement_2